Pharmafile Logo
Pharmafocus logo
Advanced Search
christianschetter

Dr. Christian Schetter hired as Chief Scientific Officer at Rentschler Biopharma

September 22, 2021
Research and Development

Rentschler Biopharma has announced the appointment of Dr. Christian Schetter as their new CSO. In this position, Schetter will be …

Appointment

HCA Healthcare to become one of MPT’s top tenants

September 22, 2021
Research and Development

Medical Properties Trust (MPT) and HCA Healthcare have agreed to a 15-year master lease for hospitals representing $1.2 billion of …

News

CHMP recommends GSK’s Nucala (mepolizumab) for three eosinophil-driven diseases

September 22, 2021
Research and Development

  GlaxoSmithKline (GSK) has announced that the Committee for Medicinal Products for Human Use (CHMP) has issued positive feedback on …

News

Novartis champion advanced breast cancer survival data at ESMO 2021

September 22, 2021
Research and Development

Novartis has presented captivating new data in advanced breast cancer, which championed the longest ever reported median overall survival, as …

News

University of Edinburgh partners with Cancer Research UK to build startup companies

September 22, 2021
Research and Development

The University of Edinburgh’s Venture Builder Incubator, a business support programme, has partnered with Cancer Research UK to help build …

News

Government report finds serious overprescription issues in England

September 22, 2021
Medical Communications, Research and Development

A government report has found serious overprescription issues in England, with 10% of items dispensed in primary care being overprescribed, …

News

J&J: Second COVID shot boosts effectiveness by 94%

September 22, 2021
Medical Communications, Research and Development

Johnson & Johnson have released data showing that a second dose of their one shot COVID-19 vaccine boosts protection from …

News

FDA: Accelerated approval for Genmab and Seagen’s TIVDAK

September 21, 2021
Manufacturing and Production, Research and Development

The FDA has granted accelerated approval for Genmab and Seagen’s TIVDAK (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate …

News
az

AstraZeneca to invest $340 million on Irish site

September 21, 2021
Manufacturing and Production

AstraZeneca has announced on Tuesday a $340 million plan to establish an active pharmaceutical ingredient (API) manufacturing facility for small …

News

Vectura removed from DDL Conference amid PMI deal

September 21, 2021
Manufacturing and Production DDL, inhalers, pmi, vectura

 Inhaler and medical device maker Vectura has been removed from pharma conferences Formulation and Delivery UK and Drug Delivery to …

News
pm_society

AstraZeneca, Klarify, and Novartis Gene Therapies top Digital Awards leaderboard

September 20, 2021
Sales and Marketing AstraZeneca, Klarify, Novartis, PM Society Awards, havas life medicom

Pharmaceutical companies AstraZeneca, Klarify, and Novartis Gene Therapies all received two gold awards at the 12th PM Society Digital Awards …

News

Singapore scientists turn discarded fruit peel into antibacterial bandages

September 20, 2021
Research and Development, Sales and Marketing

Scientists at Nanyang Technological University (NTU) in Singapore have created antibacterial organo-hydrogel bandages from discarded durian peel.The process extracts cellulose …

News

Cambodian bat researchers aiming to find COVID-19 origin

September 20, 2021
Research and Development, Sales and Marketing

An eight-member Institut Pasteur du Cambodge (IPC) research team has been collecting samples from bats in an attempt to discover …

News

ONS data shows long COVID less common than feared

September 17, 2021
Medical Communications

New data released by the Office for National Statistics (ONS) reveal that only one in 40 people with coronavirus goes …

News

NICE recommends MSD’s Keytruda for oesophageal cancer patients

September 17, 2021
Medical Communications, Research and Development

NICE has approved the use of pembrolizumab – MSD’s checkpoint inhibitor immunotherapy – in combination with platinum- and fluoropyrimidine-based chemotherapy, …

News

Health Canada announce first full approval for Moderna COVID-19 vaccine

September 17, 2021
Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna

Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …

News
moderna_norwood_plant

Moderna and Pfizer COVID-19 vaccine protection declines over time

September 16, 2021
Business Services COVID-19, FDA, Moderna, Pfizer, comirnaty

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on Friday suggest that protection from …

News

Researchers develop AI algorithm to diagnose deep vein thrombosis

September 16, 2021
Medical Communications, Research and Development

Researchers from the University of Oxford, Imperial College, and the University of Sheffield have developed a machine learning algorithm with …

News

Menstrual changes after COVID jab must be investigated, says leading immunologist

September 16, 2021
Medical Communications

Changes to periods and unexpected vaginal bleeding has been reported by 30,000 women to UK regulators, and now leading immunologist …

News

Sanofi complete acquisition of mRNA company Translate Bio

September 15, 2021
Research and Development 2021, 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026